Skip to main content
OpenTrials
Completed

NCT Number: NCT01934426

Identification of Admission High Risk Elderly

Objective: The study aim to establish high risk admission model and readmission model for elderly in Taiwan.

Method: Investigators compare the clinical, epidemiological, and socioeconomic characteristics of admitted patients during 1 August,2011 to 31 July,2012. All patients will follow up to end of study to identify 14 days readmission and 30 days readmission to geriatic ward.

Expected Outcomes: (1) To compare the prediction value of derivation cohort and validation cohort. (2) To identify high risk indicators of admission and readmission for elderly. (3) To determine the risk factors in admission elderly association with quality indicators.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with age 65 year old above
  • Patients admission to geriatric ward

Exclusion criteria

  • Patients with unstable vital sign
  • Patients or dependants reject to sign inform consent.

Treatment and study plan

Primary outcomes

  1. Determine percentages of high risk in elderly 14 days readmission to geriatric ward

    Time frame: 1-year

    Readmission in 14 days to geriatric ward is an important issue of elderly.

Sponsors and collaborators

Lead sponsor

National Taiwan University Hospital

Other

Registry information

Official study title

Identification of Admission High Risk Elderly From Multiple Cohorts: a Pilot Study

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Sep 4, 2013
Registry last updated
Apr 23, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.